Clinical Trials in Ohio

Showing 8041-8060 of 20,938 trials

Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery

NCT03319082

The objectives of this post market registry are to evaluate the safety and durability of treatment effect up to 3 years following cross-linking performed with Photrexa Viscous (riboflavin 5'- phosphate in 20% dextran ophthalmic solution), Photrexa (riboflavin 5'- phosphate ophthalmic solution), and the KXL System in patients with corneal ectasia following refractive surgery.

Corneal Ectasia

Glaukos Corporation200 participantsStarted Oct 2017

Palo Alto, California, United States • Bloomington, Minnesota, United States • Bozeman, Montana, United States +8 more locations

COMPLETEDNA32 miles

Effect of Vitamin D on the Honeymoon Period in Children and Adolescents With Type 1 Diabetes

NCT01724190

The purpose of this study is to determine if supplementation with Vitamin D in children and adolescents with newly diagnosed type 1 diabetes increases the number of patients who enter the honeymoon period.

Type 1 Diabetes

Nationwide Children's Hospital38 participantsStarted Nov 2012

Columbus, Ohio, United States

COMPLETEDNA32 miles

Cardionomic STOP-ADHF Study

NCT04814134

STOP-ADHF Study: An evaluation of the safety and performance of the Cardionomic Cardiac Pulmonary Nerve Stimulation (CPNS) system in patients with acute decompensated heart failure.

Acute Decompensated Heart Failure

Cardionomic Inc.59 participantsStarted Apr 2021

Indianapolis, Indiana, United States • Akron, Ohio, United States • Cincinnati, Ohio, United States +12 more locations

Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery

Effect of Vitamin D on the Honeymoon Period in Children and Adolescents With Type 1 Diabetes

Cardionomic STOP-ADHF Study

Find Trials by Condition in Ohio

Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

Electrically Evoked Compound Action Potentials Human Observation Medtronic Algorithm Comparison Study

Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab

Development and Testing of a Pediatric Cervical Spine Injury Risk Assessment Tool

Pilot Prospective Study: Long-term Health of Living Kidney Donors

Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM

Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer

HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network

A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer

Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors

RF Ablation of the Trigone for the Treatment of UUI

Gene Therapy With hLB-001 in Pediatric Patients With Severe Methylmalonic Acidemia

A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread

A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED)

Nivolumab Ipilimumab in Patients With hyperMutated Cancers Detected in Blood (NIMBLe)

OCS Lung System EXPAND II Trial

The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)